N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

N-3 脂肪酸诱导的 Akt 抑制：胰腺肿瘤的化学预防

• 批准号: 8296152
• 负责人: PAUL J GRIPPO
• 金额: $ 33.38万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-23 至 2017-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8296152
• 关键词: Address; Affect; Apoptosis; Apoptotic; Binding; Biological Models; Breast Cancer Cell; Cancer Cell Growth; Cell Culture Techniques; Cell Death; Cell Proliferation; Cell Survival; Cell division; Cells; Chemicals; Chemoprevention; Chemopreventive Agent; Clinical; Colon Carcinoma; Data; Development; Diet; Dietary Intervention; Dietary intake; Dinoprostone; Disease; Disease Progression; Dose; Drug Delivery Systems; Ductal; Ductal Epithelial Cell; Early Diagnosis; Epithelial; Equilibrium; Evaluation; Event; Fatty Acids; Fatty acid glycerol esters; Fish Oils; Future; Goals; Growth; Human; In Vitro; Individual; Intervention; Laboratories; Lead; Lesion; Life; Link; MEKs; Malignant Neoplasms; Malignant neoplasm of pancreas; Malignant neoplasm of prostate; Measures; Metabolism; Modality; Molecular; Mus; Nature; Noninfiltrating Intraductal Carcinoma; Normal tissue morphology; Omega-3 Fatty Acids; Pancreas; Pathway interactions; Patients; Phosphorylation; Polyunsaturated Fatty Acids; Population; Precancerous Conditions; Premalignant Cell; Process; Production; Property; Protein Dephosphorylation; Proteins; Publishing; Risk; Signal Pathway; Signal Transduction; Small Interfering RNA; Staging; Structure; System; Technology; Testing; Translating; Work; cancer cell; cancer type; cell growth; design; fatty acid metabolism; feeding; fighting; high risk; improved; in vivo; in vivo Model; malignant breast neoplasm; mouse model; mutant; neoplastic; neoplastic cell; novel strategies; outcome forecast; pancreatic neoplasm; prevent; prostaglandin E3; prostaglandin EP2 receptor; research study; response; restoration; transfection/expression vector

DESCRIPTION (provided by applicant): Several cancers and a few preinvasive lesions respond to w-3 fatty acids, which serves to promote apoptosis while blocking cellular proliferation. A similar response has been demonstrated in pancreatic cancer, although the suppressive nature of w-3 fatty acids in normal and/or neoplastic cells of the pancreas remains speculative. With the advent of modalities for earlier detection of pancreatic cancer, earlier diagnosis will soon be a reality. Hence, novel approaches to fighting these precancerous conditions must evolve, including chemoprevention, where dietary intake of fats and inhibition of key signaling pathways may reduce production of early cancer before it spreads. To examine this possibility, human pancreatic ductal epithelial (HPDE) cells with and without expression of activated Kras and mice with normal pancreas and those that develop mutant Kras-induced pancreatic precancer will be exposed to high levels of polyunsaturated fatty acids (PUFAs), w-3 and w-6. Observing cellular changes, cell proliferation, and apoptosis in normal tissue and during disease progression along with specific molecular events (activation of Akt, effects of PGE3-bound EP2 on Akt activation, phosphorylation of various proteins like Akt, Foxo, and Bad,) will determine the mechanisms of action for w-3 fatty acids in these modeling systems. The premise of this work is that w-3 fatty acids will function by generating increased levels of PGE3 which will lead to decreased pAkt in an EP2-dependent manner. Subsequent downstream events including dephosphorylation of Foxo and Bad will promote an increase in cell death and reduced cell division. Part of these evaluations will include employing w-6 fatty acids as controls but will also elucidate their potential mechanism in these modeling systems. In vitro manipulation will employ chemical inhibition or activation, siRNA technology, and transfection of expression vectors to suppress or enhance various signals in a stepwise manner through this pathway. In vivo, this work will be done in mutant Kras expressing mouse pancreas void of EP2, PI3K, Cox-2, Akt, Foxo, or Bad. In this manner, a systematic and stepwise analysis can be done at each step in the pathway to demonstrate a direct and critical link between w-3 fatty acids, the Akt pathway, and downstream events altering cell proliferation and inducing apoptosis in normal and precancerous cells of the pancreas. Understanding these processes in human cultured and mouse pancreas cells will illuminate similar dietary effects on human pancreatic precancer and cancer development while potentially providing a more effective means of inhibiting early disease processes in the human population. PUBLIC HEALTH RELEVANCE: The results from this project will provide the rationale for employing w-3 fatty acids (commonly found in fish oils) as an anticancer or chemopreventive measure. The main goal of this study is to establish the predominant means with which w-3 fatty acids oppose the development of cancer by suppressing cell growth and survival while promoting cell death. All of this work will employ either human pancreas cells in culture or living mice that develop features of human pancreatic precancer (abnormal structures that can give rise to cancer). In addition, by identifying the predominant mechanism of action of w-3 fatty acids, certain factors that respond to increased w-3 fatty acids may serve as targets for drug intervention, where the cellular effects of w- 3 fatty acids can be amplified. This type of strateg, along with restoration of a balanced w-3:w-6 fatty acid ratio in the diet, may be an effective means of managing individuals at higher risk for or with pancreatic cancer.

描述（由申请人提供）：几种癌症和一些浸润前病变对w-3脂肪酸有反应，w-3脂肪酸可促进细胞凋亡，同时阻断细胞增殖。尽管w-3脂肪酸在胰腺的正常和/或肿瘤细胞中的抑制性质仍然是推测性的，但在胰腺癌中已经证明了类似的反应。随着胰腺癌早期检测方法的出现，早期诊断将很快成为现实。因此，必须发展新的方法来对抗这些癌前病变，包括化学预防，其中脂肪的饮食摄入和关键信号通路的抑制可能会在早期癌症扩散之前减少其产生。为了检验这种可能性，将表达和不表达活化Kras的人胰腺导管上皮（HPDE）细胞、具有正常胰腺的小鼠和发展突变Kras诱导的胰腺癌前病变的小鼠暴露于高水平的多不饱和脂肪酸（PUFA）w-3和w-6。观察正常组织中和疾病进展沿着的细胞变化、细胞增殖和细胞凋亡以及特定分子事件（Akt的活化、PGE 3结合的EP 2对Akt活化的影响、各种蛋白质如Akt、Foxo和Bad的磷酸化）将确定w-3脂肪酸在这些建模系统中的作用机制。这项工作的前提是w-3脂肪酸将通过产生增加的PGE 3水平发挥作用，这将导致以EP 2依赖性方式降低pAkt。随后的下游事件包括Foxo和Bad的去磷酸化将促进细胞死亡的增加和细胞分裂的减少。这些评估的一部分将包括采用w-6脂肪酸作为对照，但也将阐明它们在这些建模系统中的潜在机制。体外操作将采用化学抑制或激活、siRNA技术和表达载体的转染，以通过该途径以逐步的方式抑制或增强各种信号。在体内，该工作将在表达无EP 2、PI 3 K、考克斯-2、Akt、Foxo或Bad的小鼠胰腺的突变Kras中进行。以这种方式，可以在途径中的每个步骤进行系统的和逐步的分析，以证明w-3脂肪酸、Akt途径和改变细胞增殖和诱导胰腺正常和癌前细胞凋亡的下游事件之间的直接和关键的联系。了解人类培养和小鼠胰腺细胞中的这些过程将阐明饮食对人类胰腺癌前病变和癌症发展的类似影响，同时可能提供一种更有效的抑制人类早期疾病过程的方法。 公共卫生关系：这个项目的结果将为使用w-3脂肪酸（通常在鱼油中发现）作为抗癌或化学预防措施提供理论基础。这项研究的主要目的是建立w-3脂肪酸通过抑制细胞生长和存活同时促进细胞死亡来对抗癌症发展的主要手段。所有这些工作都将使用培养或活体的人类胰腺细胞 小鼠发展出人类胰腺癌前病变的特征（可能导致癌症的异常结构）。此外，通过确定w-3脂肪酸的主要作用机制，某些对w-3脂肪酸增加有反应的因子可以作为药物干预的靶点，其中w- 3脂肪酸的细胞效应可以被放大。这种类型的策略，沿着恢复饮食中w-3：w-6脂肪酸比例的平衡，可能是管理胰腺癌高危人群或胰腺癌患者的有效手段。